Physician profile
Brian R Wolf
NPI 1255326732
$298,274.05
in general payments reported to CMS, 2019-2025
7 companies · $75K in 2025
The $75K reported for 2025 was more than what 96% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $14K · 2021: $27K · 2022: $24K · 2023: $84K · 2024: $59K · 2025: $75K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $200K · Consulting Fee: $16K · Food and Beverage: $759 · Travel and Lodging: $366.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $200,095.18 |
| Consulting Fee | $15,850.00 |
| Food and Beverage | $759.26 |
| Travel and Lodging | $366.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $297,473.81 | 2019-2025 | Ezstart, Knee Biologics, Infinity Knee System |
| Zimmer Biomet Holdings, INC. | $247.82 | 2023-2024 | Tapestry |
| Stryker Corporation | $233.35 | 2023-2025 | Iconix |
| Medacta USA, INC. | $125.00 | 2022 | |
| Arthrex, INC. | $95.29 | 2020 | |
| Smith+Nephew, INC. | $85.19 | 2020-2023 | |
| Depuy Synthes Sales INC. | $13.59 | 2023 | Attune |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.